Greg Rossi discusses the imperative to address cancer in Europe with early detection, precision medicine and equitable access. Stressing the need for urgent action to make cancer a manageable condition, highlighting disparities and the importance of innovation.
Targeted oncology treatments, enabled by biomarker testing, are leading a ‘Renaissance’ in the fight against cancer. To make full use of their potential, we need multi-stakeholder action in overcoming Europe’s testing infrastructure gaps and making testing more accessible.
Innovation in science is advancing cancer care through early detection and treatment, bringing significant economic benefits to healthcare systems. Future incentives for innovation, particularly early detection and treatment approaches, must be recognised so that patients can benefit from this progress.
More and more innovative drugs and biomarkers for cancer are being developed, which is why the coordinator of the OncoLAB Advisory Board, Dr. Ana Rodríguez Cala, assures that "we need to hurry up" to introduce the new treatments into the …
The EU's ambitious plans to beat cancer would be complemented by taking greater account of how complementary therapies can improve quality of life alongside medical treatment, panellists argued at a EURACTIV event on ‘Integrative oncology’.
Cancer is a top health priority for the European Union, as every year, 3.5 million people in the EU are diagnosed with cancer, and 1.3 million die from it.
There is a large inequality of access to women's cancer services and treatments across the block, according to the EU health chief, who highlighted the role of Europe's Beating Cancer plan in bridging these disparities.
We’re all in the race of our lives to beat COVID-19. Scientists are setting an astonishing pace in a team effort with healthcare professionals, policymakers and entire populations. But at the same time it’s imperative we maintain the momentum we’ve …
Download PDF
Despite the solid evidence that outdoor workers in various workplaces across Europe are exposed to elevated levels of UV radiation and are consequently at a significantly increased risk of developing non-melanoma skin cancer (NMSC), this evidence has yet not been translated into a common European regulatory approach.
The President of the European Commission launched an EU-wide public consultation on Europe's Beating Cancer Plan on Tuesday (4 February), announcing an EU-wide "open health data space" in support of research, prevention and cure.
